SBIR/STTR Research Award
SBIR Phase I: High-throughput injectability screening of high concentration protein formulations by multiplexed microfluidic quartz resonators
Award amount
$255,748Program and phase
SBIR · Phase IAward year
2020Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- QATCH TECHNOLOGIES LLC
- Proposal award date
- 2020-09-01
- Contract end date
- 2021-02-28
- UEI
- D5FFZ7RBVYH7
- Solicitation number
- Not reported
- Topic code
- BT
Research abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project advances a new type of drug delivery. Protein-based drugs (biologics) have become more popular due to their high specificity of activity and generall
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- High-throughput injectability screening of high concentration protein formulations by microfluidic quartz resonators
- Developing prototype injectability and developability testing system based on microfluidic quartz resonators
- Microcapillary Quartz Sensors for Screening Injectability of High Concentration Protein Formulations
- Injectability analysis of high concentration protein formulations by extending shear-rate range in microfluidic quartz viscometers
- Microcapillary Quartz Sensors for Screening Injectability of High Concentration Protein Formulations
Research funding history
7 SBIR/STTR records share this UEI (2017–2023). Reported award amounts total $4,613,801. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, Department of Commerce